Derma Sciences (DSCI) Tops Q1 EPS by 6c; Outlook Affirmed
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Derma Sciences Reports 2016 First Quarter Financial Results
May 11, 2016 7:30 AM EDT
Net sales up 3.8% with Advanced Wound Care sales up 8.5%
Affirms
2016 financial guidance
Conference call begins at 11:00 a.m. Eastern Time today
PRINCETON, N.J.--(BUSINESS WIRE)-- Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three months ended March 31, 2016.
Financial highlights of the first quarter of 2016 include (all comparisons are with the first quarter of 2015 unless otherwise noted):
Advanced Wound Care (AWC) net sales were... More